Salmedix

San Diego, United States Founded: 2000 • Age: 26 yrs Acquired By Cephalon
Drugs for hematologic cancers are developed using prior clinical data.
Request Access

About Salmedix

Salmedix is a company based in San Diego (United States) founded in 2000 was acquired by Cephalon in May 2005.. Salmedix has raised $72.5 million across 3 funding rounds from investors including ARE, Orbimed and Cephalon. Salmedix operates in a competitive market with competitors including Adicet Bio, Orca Bio, Ossium Health, Auron Therapeutics and Nordic Nanovector, among others.

  • Headquarter San Diego, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $72.5 M (USD)

    in 3 rounds

  • Latest Funding Round
    $45 M (USD), Series C

    Oct 19, 2005

  • Investors
    ARE

    & 18 more

  • Employee Count
    Employee Count
  • Acquired by
    Cephalon

    (May 12, 2005)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Salmedix

Salmedix has successfully raised a total of $72.5M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $45 million completed in October 2005. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 3
  • Last Round Series C — $45.0M
  • First Round

    (19 Jun 2002)

  • Investors Count 18
Date Amount Transaction Name Valuation Lead Investors Investors
Oct, 2005 Amount Series C - Salmedix Valuation

investors

Jun, 2004 Amount Series C - Salmedix Valuation

investors

Jun, 2002 Amount Series B - Salmedix Valuation Garywoitzik , Delphi Ventures
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Salmedix

Salmedix has secured backing from 19 investors, including institutional and venture fund investors. Prominent investors backing the company include ARE, Orbimed and Cephalon. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
Founded Year Domain Location
-
Founded Year Domain Location
Early-stage investing in IT and healthcare ventures.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Salmedix

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Salmedix

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Salmedix Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Salmedix

Salmedix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Adicet Bio, Orca Bio, Ossium Health, Auron Therapeutics and Nordic Nanovector, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Immune cell therapies for cancer treatment are developed.
domain founded_year HQ Location
Developer of Allogeneic cell therapy for cancer, autoimmune diseases and genetic blood disorders
domain founded_year HQ Location
Ossium Health is focused on bioengineering for improved health.
domain founded_year HQ Location
Developer of cancer therapeutics for the treatment of blood cancer
domain founded_year HQ Location
Antibody radionuclide conjugates are developed for haematological cancers.
domain founded_year HQ Location
Monoclonal antibody therapies for pediatric leukemia are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Salmedix

Frequently Asked Questions about Salmedix

When was Salmedix founded?

Salmedix was founded in 2000 and raised its 1st funding round 2 years after it was founded.

Where is Salmedix located?

Salmedix is headquartered in San Diego, United States. It is registered at San Diego, California, United States.

Is Salmedix a funded company?

Salmedix is a funded company, having raised a total of $72.5M across 3 funding rounds to date. The company's 1st funding round was a Series B of $27.5M, raised on Jun 19, 2002.

What does Salmedix do?

Salmedix was founded in 2000 and is based in San Diego, United States. Operations are conducted in the biotechnology sector, where compounds for treating hematologic cancers are developed. Prior human clinical data is leveraged in these compounds to enable a shorter and less costly development timeline. The lead pipeline product, SDX-105, is targeted at non-Hodgkins lymphoma.

Who are the top competitors of Salmedix?

Salmedix's top competitors include Orca Bio, Ossium Health and Adicet Bio.

Who are Salmedix's investors?

Salmedix has 19 investors. Key investors include ARE, Orbimed, Cephalon, Bemberg Capital, and H.I.G. Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available